A new study to be published in the July issue of the Journal of the American College of Surgeons shows that one academic medical center recouped its investment in electronic health records within 16 months. The new analysis counters concerns of health care providers reluctant to invest in electronic medical records systems.
Hispanic women with hypertension and coronary artery disease respond better to drug regimens aimed at controlling high blood pressure than non-Hispanic white women, University of Florida researchers report.
Changes to health services in London are long overdue but it is unclear how the latest proposals announced by London Strategic Health Authority, would improve patient care in the capital, BMA leaders claim.
Anemia is one of the most frequent complications of hemodialysis, and its correction is an important factor in restoring a tolerable quality of life to dialysis-dependent patients.
Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues.
Prostate cancer is the most common cancer in American men, with an estimated incidence of 234,460 cases and 27,360 deaths in 2006. Screening for prostate cancer remains controversial due to insufficient evidence to recommend for or against screening.
While the overall cost-effectiveness of Medicare benefits have been much-debated, new data now show that people who were uninsured before receiving benefits at age 65 required more intensive and costlier care than those who had been privately insured prior to receiving Medicare.
Nearly 90 percent of all babies born in the United States ? more than double the percentage in 2005 ? live in states that require screening for at least 21 life-threatening disorders, according to the latest March of Dimes Newborn Screening Report Card.
Silence may impact women?s health since few women or their doctors are comfortable talking about vaginal health openly. This hesitation, combined with a limited understanding of the differences between women, can lead to misinformation, misdiagnosis and potentially ineffective treatments.
A Penn State researcher argues that ambiguous international rules outlining when and how governments may “break” pharmaceutical patents may end up significantly reducing incentives for innovation while at the same time failing to increase access to medicines.